{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:22:11Z","timestamp":1778253731042,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Urothelial carcinoma is a prevalent malignancy within the United States that may involve the upper and\/or lower urinary tracts. Multimodal treatment is often employed, with transurethral resection and intravesical therapy standard of care for non-muscle-invasive disease; neoadjuvant systemic therapy followed by radical cystectomy or trimodal therapy for muscle-invasive disease; and combination immune checkpoint inhibitors and antibody-drug conjugates standard of care for metastatic disease. These treatments carry risks of surgical complication or treatment-associated toxicity which can impair quality of life. Predictive biomarkers of treatment tolerability are currently limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>There is emerging evidence that radiological biomarkers can predict treatment outcomes among patients with urothelial carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>In this review, we evaluate the existing data on radiological biomarkers evaluable from current standard-of-care imaging in predicting treatment outcome among patients with urothelial carcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11934-025-01278-0","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T03:17:26Z","timestamp":1750475846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Re-appraisal of Standard of Care Imaging to Identify Predictors of Treatment Outcomes among Patients with Bladder and Upper Tract Urothelial Cancers"],"prefix":"10.1007","volume":"26","author":[{"given":"Shelby","family":"Harper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick M.","family":"Remer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Almassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"1278_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/CAAC.21820.","DOI":"10.3322\/CAAC.21820"},{"key":"1278_CR2","unstructured":"NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer. V.7.2024. National Comprehensive Cancer Network, Inc. 2024. Accessed January 5, 2025."},{"issue":"1","key":"1278_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/J.UROLOGY.2011.02.038","volume":"78","author":"AK Smith","year":"2011","unstructured":"Smith AK, Stephenson AJ, Lane BR, et al. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for Conservative management. Urology. 2011;78(1):82\u20136. https:\/\/doi.org\/10.1016\/J.UROLOGY.2011.02.038.","journal-title":"Urology"},{"key":"1278_CR4","doi-asserted-by":"publisher","unstructured":"Cho MR, Lee S, Song SK. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction. J Korean Med Sci. 2022;37(18). https:\/\/doi.org\/10.3346\/JKMS.2022.37.E146.","DOI":"10.3346\/JKMS.2022.37.E146"},{"issue":"20","key":"1278_CR5","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","volume":"147","author":"AA Damluji","year":"2023","unstructured":"Damluji AA, Alfaraidhy M, AlHajri N, et al. Sarcopenia and cardiovascular diseases. Circulation. 2023;147(20):1534\u201353. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.064071.","journal-title":"Circulation"},{"issue":"9","key":"1278_CR6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/GERONA\/GLX245","volume":"73","author":"LA Schaap","year":"2018","unstructured":"Schaap LA, Van Schoor NM, Lips P, Visser M. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: the longitudinal aging study Amsterdam. J Gerontol Biol Sci Med Sci. 2018;73(9):1199\u2013204. https:\/\/doi.org\/10.1093\/GERONA\/GLX245.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"12","key":"1278_CR7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jamda.2016.09.013","volume":"17","author":"KV Chang","year":"2016","unstructured":"Chang KV, Hsu TH, Wu WT, Huang KC, Han DS. Association between sarcopenia and cognitive impairment: A systematic review and Meta-Analysis. J Am Med Dir Assoc. 2016;17(12):1164..e7-1164.e15.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"1278_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/JCSM.12149","volume":"8","author":"C Beaudart","year":"2017","unstructured":"Beaudart C, Biver E, Reginster JY, et al. Validation of the SarQoL\u00ae, a specific health-related quality of life questionnaire for sarcopenia. J Cachexia Sarcopenia Muscle. 2017;8(2):238\u201344. https:\/\/doi.org\/10.1002\/JCSM.12149.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"1278_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/JCSM.12160","volume":"8","author":"L dos Santos","year":"2017","unstructured":"dos Santos L, Cyrino ES, Antunes M, Santos DA, Sardinha LB. Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function. J Cachexia Sarcopenia Muscle. 2017;8(2):245\u201350. https:\/\/doi.org\/10.1002\/JCSM.12160.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"1278_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/EJCN.2014.117","volume":"68","author":"JA Batsis","year":"2014","unstructured":"Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National health and nutrition examination survey III. Eur J Clin Nutr. 2014;68(9):1001\u20137. https:\/\/doi.org\/10.1038\/EJCN.2014.117.","journal-title":"Eur J Clin Nutr"},{"issue":"4","key":"1278_CR11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3945\/AJCN.113.070466","volume":"100","author":"YY Al-Gindan","year":"2014","unstructured":"Al-Gindan YY, Hankey C, Govan L, Gallagher D, Heymsfield SB, Lean MEJ. Derivation and validation of simple equations to predict total muscle mass from simple anthropometric and demographic data. Am J Clin Nutr. 2014;100(4):1041\u201351. https:\/\/doi.org\/10.3945\/AJCN.113.070466.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"1278_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/J.JAMDA.2014.11.011","volume":"16","author":"DM Mijnarends","year":"2015","unstructured":"Mijnarends DM, Schols JMGA, Meijers JMM, et al. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: similarities and discrepancies. J Am Med Dir Assoc. 2015;16(4):301\u20138. https:\/\/doi.org\/10.1016\/J.JAMDA.2014.11.011.","journal-title":"J Am Med Dir Assoc"},{"issue":"9","key":"1278_CR13","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/S00261-021-03294-3","volume":"47","author":"V Chianca","year":"2022","unstructured":"Chianca V, Albano D, Messina C, et al. Sarcopenia: imaging assessment and clinical application. Abdom Radiol (New York). 2022;47(9):3205\u201316. https:\/\/doi.org\/10.1007\/S00261-021-03294-3.","journal-title":"Abdom Radiol (New York)"},{"issue":"6","key":"1278_CR14","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/JAMAONCOL.2018.0137","volume":"4","author":"BJ Caan","year":"2018","unstructured":"Caan BJ, Cespedes Feliciano EM, Prado CM, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast Cancer. JAMA Oncol. 2018;4(6):798\u2013804. https:\/\/doi.org\/10.1001\/JAMAONCOL.2018.0137.","journal-title":"JAMA Oncol"},{"key":"1278_CR15","doi-asserted-by":"publisher","unstructured":"Sakurai K, Kubo N, Tamamori Y, et al. Depletion of skeletal muscle mass adversely affects long-term outcomes for men undergoing gastrectomy for gastric cancer. PLoS ONE. 2021;16(8). https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0256365.","DOI":"10.1371\/JOURNAL.PONE.0256365"},{"issue":"10","key":"1278_CR16","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/S11605-018-3802-1","volume":"22","author":"J Chakedis","year":"2018","unstructured":"Chakedis J, Spolverato G, Beal EW, et al. Pre-operative sarcopenia identifies patients at risk for poor survival after resection of biliary tract cancers. J Gastrointest Surg. 2018;22(10):1697\u2013708. https:\/\/doi.org\/10.1007\/S11605-018-3802-1.","journal-title":"J Gastrointest Surg"},{"issue":"18","key":"1278_CR17","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1002\/CNCR.28798","volume":"120","author":"SP Psutka","year":"2014","unstructured":"Psutka SP, Carrasco A, Schmit GD, et al. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer. 2014;120(18):2910\u20138. https:\/\/doi.org\/10.1002\/CNCR.28798.","journal-title":"Cancer"},{"key":"1278_CR18","doi-asserted-by":"publisher","unstructured":"Rozynek M, Kucyba\u0142a I, Urbanik A, Wojciechowski W. Use of artificial intelligence in the imaging of sarcopenia: A narrative review of current status and perspectives. Nutrition. 2021;89. https:\/\/doi.org\/10.1016\/J.NUT.2021.111227.","DOI":"10.1016\/J.NUT.2021.111227"},{"issue":"1","key":"1278_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2214\/AJR.22.28745","volume":"221","author":"B Dustin Pooler","year":"2023","unstructured":"Dustin Pooler B, Garrett JW, Southard AM, Summers RM, Pickhardt PJ. Technical adequacy of fully automated artificial intelligence body composition tools: assessment in a heterogeneous sample of external CT examinations. AJR Am J Roentgenol. 2023;221(1):124\u201334. https:\/\/doi.org\/10.2214\/AJR.22.28745.","journal-title":"AJR Am J Roentgenol"},{"key":"1278_CR20","doi-asserted-by":"publisher","unstructured":"Pooler BD, Garrett JW, Lee MH, et al. CT-Based body composition measures and systemic disease: A Population-Level analysis using artificial intelligence tools in over 100,000 patients. AJR Am J Roentgenol Published Online January. 2025;8. https:\/\/doi.org\/10.2214\/AJR.24.32216.","DOI":"10.2214\/AJR.24.32216"},{"key":"1278_CR21","doi-asserted-by":"publisher","unstructured":"Ahmad N, Strand R, Sparres\u00e4ter B, et al. Automatic segmentation of large-scale CT image datasets for detailed body composition analysis. BMC Bioinformatics. 2023;24(1). https:\/\/doi.org\/10.1186\/S12859-023-05462-2.","DOI":"10.1186\/S12859-023-05462-2"},{"issue":"1","key":"1278_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2008.07.031","volume":"55","author":"A Shabsigh","year":"2009","unstructured":"Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder Cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164\u201376. https:\/\/doi.org\/10.1016\/j.eururo.2008.07.031.","journal-title":"Eur Urol"},{"issue":"13","key":"1278_CR23","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMOA2401497","volume":"391","author":"SP Lerner","year":"2024","unstructured":"Lerner SP, Tangen C, Svatek RS, et al. Standard or extended lymphadenectomy for Muscle-Invasive bladder Cancer. N Engl J Med. 2024;391(13):1206\u201316. https:\/\/doi.org\/10.1056\/NEJMOA2401497.","journal-title":"N Engl J Med"},{"issue":"6","key":"1278_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/J.EUF.2023.05.002","volume":"9","author":"S Katsimperis","year":"2023","unstructured":"Katsimperis S, Tzelves L, Tandogdu Z, et al. Complications after radical cystectomy: A systematic review and Meta-analysis of randomized controlled trials with a Meta-regression analysis. Eur Urol Focus. 2023;9(6):920\u20139. https:\/\/doi.org\/10.1016\/J.EUF.2023.05.002.","journal-title":"Eur Urol Focus"},{"issue":"3","key":"1278_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/JU.0000000000000570","volume":"203","author":"JJH Zhang","year":"2020","unstructured":"Zhang JJH, Ericson KJ, Thomas LJ, et al. Large single institution comparison of perioperative outcomes and complications of open radical cystectomy, intracorporeal Robot-Assisted radical cystectomy and robotic extracorporeal approach. J Urol. 2020;203(3):512\u201321. https:\/\/doi.org\/10.1097\/JU.0000000000000570.","journal-title":"J Urol"},{"issue":"3","key":"1278_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/J.EURURO.2021.09.018","volume":"81","author":"MB Clements","year":"2022","unstructured":"Clements MB, Atkinson TM, Dalbagni GM, et al. Health-related quality of life for patients undergoing radical cystectomy: results of a large prospective cohort. Eur Urol. 2022;81(3):294\u2013304. https:\/\/doi.org\/10.1016\/J.EURURO.2021.09.018.","journal-title":"Eur Urol"},{"issue":"21","key":"1278_CR27","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1001\/JAMA.2022.7393","volume":"327","author":"JWF Catto","year":"2022","unstructured":"Catto JWF, Khetrapal P, Ricciardi F, et al. Effect of Robot-Assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy on 90-Day morbidity and mortality among patients with bladder cancer: A randomized clinical trial. JAMA. 2022;327(21):2092\u2013103. https:\/\/doi.org\/10.1001\/JAMA.2022.7393.","journal-title":"JAMA"},{"issue":"2","key":"1278_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/00369330241234690","volume":"69","author":"F Qin","year":"2024","unstructured":"Qin F, Wu J. Impact of sarcopenia on outcomes of bladder cancer undergoing radical cystectomy: A systematic review and meta-analysis. Scott Med J. 2024;69(2):26\u201336. https:\/\/doi.org\/10.1177\/00369330241234690.","journal-title":"Scott Med J"},{"issue":"6","key":"1278_CR29","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.juro.2013.12.047","volume":"191","author":"AB Smith","year":"2014","unstructured":"Smith AB, Deal AM, Yu H, et al. Sarcopenia as a predictor of complications and survival following radical cystectomy. J Urol. 2014;191(6):1714\u201320. https:\/\/doi.org\/10.1016\/j.juro.2013.12.047.","journal-title":"J Urol"},{"issue":"8","key":"1278_CR30","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/S00345-018-2259-X","volume":"36","author":"R Mayr","year":"2018","unstructured":"Mayr R, Fritsche HM, Zeman F, et al. Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer. World J Urol. 2018;36(8):1201\u20137. https:\/\/doi.org\/10.1007\/S00345-018-2259-X.","journal-title":"World J Urol"},{"issue":"6","key":"1278_CR31","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/JU.0000000000000450","volume":"202","author":"J Albersheim","year":"2019","unstructured":"Albersheim J, Sathianathen NJ, Zabell J, et al. Skeletal muscle and fat mass indexes predict discharge disposition after radical cystectomy. J Urol. 2019;202(6):1143\u20139. https:\/\/doi.org\/10.1097\/JU.0000000000000450.","journal-title":"J Urol"},{"key":"1278_CR32","doi-asserted-by":"publisher","unstructured":"Sharma V, Fadel A, Tollefson MK, et al. Artificial Intelligence-Based assessment of preoperative body composition is associated with early complications after radical cystectomy. J Urol. 2025;213(2). https:\/\/doi.org\/10.1097\/JU.0000000000004292.","DOI":"10.1097\/JU.0000000000004292"},{"issue":"4","key":"1278_CR33","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0022-5347(05)00644-0","volume":"175","author":"CT Lee","year":"2006","unstructured":"Lee CT, Madii R, Daignault S, et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol. 2006;175(4):1262\u20137. https:\/\/doi.org\/10.1016\/S0022-5347(05)00644-0.","journal-title":"J Urol"},{"key":"1278_CR34","doi-asserted-by":"publisher","unstructured":"Mayr R, May M, Martini T, et al. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. BJU Int. 2012;110. https:\/\/doi.org\/10.1111\/J.1464-410X.2012.10938.X","DOI":"10.1111\/J.1464-410X.2012.10938.X"},{"key":"1278_CR35","doi-asserted-by":"publisher","unstructured":"Lambert JW, Ingham M, Gibbs BB, Given RW, Lance RS, Riggs SB. Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer. Urology. 2013;81(3):587-592 https:\/\/doi.org\/10.1016\/J.UROLOGY.2012.10.055","DOI":"10.1016\/J.UROLOGY.2012.10.055"},{"key":"1278_CR36","doi-asserted-by":"publisher","unstructured":"Chesnut GT, Tin AL, Sjoberg DD et al. Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes following Radical Cystectomy. J Urol. 2021;205(2):400\u2013406. https:\/\/doi.org\/10.1097\/JU.0000000000001360","DOI":"10.1097\/JU.0000000000001360"},{"issue":"2","key":"1278_CR37","doi-asserted-by":"publisher","first-page":"108e","DOI":"10.1016\/j.urolonc.2022.10.017","volume":"41","author":"WW Smelser","year":"2023","unstructured":"Smelser WW, Tallman JE, Gupta VK, et al. Implementation of a comprehensive prehabilitation program for patients undergoing radical cystectomy. Urol Oncol. 2023;41(2):108e. 19-108.e27.","journal-title":"Urol Oncol"},{"issue":"3","key":"1278_CR38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/J.JURO.2018.10.010","volume":"201","author":"CR Ritch","year":"2019","unstructured":"Ritch CR, Cookson MS, Clark PE, et al. Perioperative oral nutrition supplementation reduces prevalence of sarcopenia following radical cystectomy: results of a prospective randomized controlled trial. J Urol. 2019;201(3):470\u20137. https:\/\/doi.org\/10.1016\/J.JURO.2018.10.010.","journal-title":"J Urol"},{"issue":"9","key":"1278_CR39","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1056\/NEJMoa022148","volume":"349","author":"HB Grossman","year":"2003","unstructured":"Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder Cancer. N Engl J Med. 2003;349(9):859\u201366. https:\/\/doi.org\/10.1056\/NEJMoa022148.","journal-title":"N Engl J Med"},{"issue":"17","key":"1278_CR40","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","volume":"18","author":"H Von der Maase","year":"2000","unstructured":"Von der Maase H, Hansen SW, Roberts JT, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol. 2000;18(17):3068\u201377. https:\/\/doi.org\/10.1200\/JCO.2000.18.17.3068.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1278_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/S00345-015-1636-Y","volume":"34","author":"EEF van de Putte","year":"2016","unstructured":"van de Putte EEF, Mertens LS, Meijer RP, et al. Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine\/cisplatin. World J Urol. 2016;34(2):157\u201362. https:\/\/doi.org\/10.1007\/S00345-015-1636-Y.","journal-title":"World J Urol"},{"issue":"18","key":"1278_CR42","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1200\/JCO.21.02051","volume":"40","author":"C Pfister","year":"2022","unstructured":"Pfister C, Gravis G, Fl\u00e9chon A, et al. Dose-Dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic Muscle-Invasive bladder cancer: results of the GETUG-AFU V05 VESPER trial. J Clin Oncol. 2022;40(18):2013\u201322. https:\/\/doi.org\/10.1200\/JCO.21.02051.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1278_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/S41585-020-00404-6","volume":"18","author":"DM Jiang","year":"2021","unstructured":"Jiang DM, Gupta S, Kitchlu A, et al. Defining cisplatin eligibility in patients with muscle-invasive bladder cancer. Nat Rev Urol. 2021;18(2):104\u201314. https:\/\/doi.org\/10.1038\/S41585-020-00404-6.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"1278_CR44","doi-asserted-by":"publisher","first-page":"e879","DOI":"10.1016\/J.CLGC.2018.02.002","volume":"16","author":"VS Koshkin","year":"2018","unstructured":"Koshkin VS, Barata PC, Rybicki LA, et al. Feasibility of Cisplatin-Based neoadjuvant chemotherapy in Muscle-Invasive bladder Cancer patients with diminished renal function. Clin Genitourin Cancer. 2018;16(4):e879\u201392. https:\/\/doi.org\/10.1016\/J.CLGC.2018.02.002.","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"1278_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/BJA\/85.1.109","volume":"85","author":"JP Desborough","year":"2000","unstructured":"Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85(1):109\u201317. https:\/\/doi.org\/10.1093\/BJA\/85.1.109.","journal-title":"Br J Anaesth"},{"issue":"1","key":"1278_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/BLC-160080","volume":"3","author":"H Zargar","year":"2017","unstructured":"Zargar H, Almassi N, Kovac E, et al. Change in Psoas muscle volume as a predictor of outcomes in patients treated with chemotherapy and radical cystectomy for muscle-Invasive bladder Cancer. Bl cancer (Amsterdam Netherlands). 2017;3(1):57\u201363. https:\/\/doi.org\/10.3233\/BLC-160080.","journal-title":"Bl cancer (Amsterdam Netherlands)"},{"key":"1278_CR47","doi-asserted-by":"publisher","unstructured":"Lyon TD, Frank I, Takahashi N, Sarcopenia, Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2-19;17(3):216-222.e5. https:\/\/doi.org\/10.1111\/BJU.16606","DOI":"10.1111\/BJU.16606"},{"key":"1278_CR48","doi-asserted-by":"publisher","unstructured":"Werneburg GT, Hettel D, Jeong S, Nemunaitis G, Taliercio JJ, Wood HM. Estimated Glomerular Filtration Rate Using Cystatin C is a More Sensitive Marker for Kidney Dysfunction in Nonweight-bearing Individuals. J Urol. 2023;209(2):391\u2013398. https:\/\/doi.org\/10.1097\/JU.0000000000003070","DOI":"10.1097\/JU.0000000000003070"},{"key":"1278_CR49","doi-asserted-by":"publisher","unstructured":"Haile, Lone ES, Shin Z et al. D, Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function. BJU Int. 2024. https:\/\/doi.org\/10.1111\/BJU.16606","DOI":"10.1111\/BJU.16606"},{"key":"1278_CR50","doi-asserted-by":"publisher","unstructured":"Lone Z, Shin D, Nowacki A, et al. Body morphometry May predict parastomal hernia following radical cystectomy with ileal conduit. BJU Int. 2024;134(5). https:\/\/doi.org\/10.1111\/BJU.16434","DOI":"10.1111\/BJU.16434"},{"issue":"10","key":"1278_CR51","doi-asserted-by":"publisher","first-page":"O191","DOI":"10.1111\/CODI.13065","volume":"17","author":"JR Lambrecht","year":"2015","unstructured":"Lambrecht JR, Larsen SG, Reiertsen O, Vaktskjold A, Julsrud L, Flatmark K. Prophylactic mesh at end-colostomy construction reduces parastomal hernia rate: a randomized trial. Colorectal Dis. 2015;17(10):O191\u20137. https:\/\/doi.org\/10.1111\/CODI.13065.","journal-title":"Colorectal Dis"},{"issue":"4","key":"1278_CR52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/SLA.0000000000001903","volume":"265","author":"HT Brandsma","year":"2017","unstructured":"Brandsma HT, Hansson BME, Aufenacker TJ, et al. Prophylactic mesh placement during formation of an End-colostomy reduces the rate of parastomal hernia: Short-term results of the Dutch PREVENT-trial. Ann Surg. 2017;265(4):663\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000001903.","journal-title":"Ann Surg"},{"issue":"5","key":"1278_CR53","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/J.EURURO.2020.07.033","volume":"78","author":"F Liedberg","year":"2020","unstructured":"Liedberg F, Kollberg P, Allerbo M, et al. Preventing parastomal hernia after ileal conduit by the use of a prophylactic mesh: A randomised study. Eur Urol. 2020;78(5):757\u201363. https:\/\/doi.org\/10.1016\/J.EURURO.2020.07.033.","journal-title":"Eur Urol"},{"issue":"5S","key":"1278_CR54","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1097\/01.JU.0001008768.36634.79.08","volume":"211","author":"TF Donahue","year":"2024","unstructured":"Donahue TF, Assel M, Pekala K, Doudt A, Tallman J, Pietzak E, Cha EK, Dalbagni G, McCarter M, Liso N, Vickers A, Vargas A, Fleming S, Bochner B. PD34-08 A prospective randomized phase 3 trial evaluating benefits of peristomal mesh placement at the time of radical cystectomy and ileal conduit formation. J Urol. 2024;211(5S):e721.","journal-title":"J Urol"},{"issue":"29","key":"1278_CR55","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1200\/JCO.2013.54.3173","volume":"32","author":"A Gupta","year":"2014","unstructured":"Gupta A, Atoria CL, Ehdaie B, et al. Risk of fracture after radical cystectomy and urinary diversion for bladder Cancer. J Clin Oncol. 2014;32(29):3291\u20138. https:\/\/doi.org\/10.1200\/JCO.2013.54.3173.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1278_CR56","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1359\/JBMR.2000.15.6.993","volume":"15","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Min Res. 2000;15(6):993\u20131000. https:\/\/doi.org\/10.1359\/JBMR.2000.15.6.993.","journal-title":"J Bone Min Res"},{"key":"1278_CR57","doi-asserted-by":"publisher","unstructured":"Chalitsios CV, Shaw DE, McKeever TM. Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis. Respir Med. 2021;181. https:\/\/doi.org\/10.1016\/J.RMED.2021.106374.","DOI":"10.1016\/J.RMED.2021.106374"},{"issue":"10","key":"1278_CR58","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1634\/THEONCOLOGIST.11-10-1121","volume":"11","author":"TA Guise","year":"2006","unstructured":"Guise TA. Bone loss and fracture risk associated with cancer therapy. Oncologist. 2006;11(10):1121\u201331. https:\/\/doi.org\/10.1634\/THEONCOLOGIST.11-10-1121.","journal-title":"Oncologist"},{"issue":"18","key":"1278_CR59","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","volume":"367","author":"S Boonen","year":"2012","unstructured":"Boonen S, Reginster JY, Kaufman JM, et al. Fracture risk and Zoledronic acid therapy in men with osteoporosis. N Engl J Med. 2012;367(18):1714\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1204061.","journal-title":"N Engl J Med"},{"issue":"25","key":"1278_CR60","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","volume":"379","author":"IR Reid","year":"2018","unstructured":"Reid IR, Horne AM, Mihov B, et al. Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med. 2018;379(25):2407\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1808082.","journal-title":"N Engl J Med"},{"issue":"12","key":"1278_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/NU12123743","volume":"12","author":"T Inoue","year":"2020","unstructured":"Inoue T, Maeda K, Nagano A, et al. Undernutrition, sarcopenia, and frailty in fragility hip fracture: advanced strategies for improving clinical outcomes. Nutrients. 2020;12(12):1\u201328. https:\/\/doi.org\/10.3390\/NU12123743.","journal-title":"Nutrients"},{"key":"1278_CR62","doi-asserted-by":"publisher","unstructured":"Marra M, Sammarco R, De Lorenzo A et al. Assessment of Body Composition in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical Overview. Contrast Media Mol Imaging. 2019. https:\/\/doi.org\/10.1155\/2019\/3548284","DOI":"10.1155\/2019\/3548284"},{"issue":"4","key":"1278_CR63","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3171\/2022.11.SPINE22875","volume":"38","author":"N Deshpande","year":"2023","unstructured":"Deshpande N, Hadi MS, Lillard JC, et al. Alternatives to DEXA for the assessment of bone density: a systematic review of the literature and future recommendations. J Neurosurg Spine. 2023;38(4):436\u201345. https:\/\/doi.org\/10.3171\/2022.11.SPINE22875.","journal-title":"J Neurosurg Spine"},{"issue":"9","key":"1278_CR64","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/S00198-020-05670-Z","volume":"32","author":"K Kim","year":"2021","unstructured":"Kim K, Song SH, Kim IJ, Jeon YK. Is dual-energy absorptiometry accurate in the assessment of bone status of patients with chronic kidney disease? Osteoporos Int. 2021;32(9):1859\u201368. https:\/\/doi.org\/10.1007\/S00198-020-05670-Z.","journal-title":"Osteoporos Int"},{"issue":"1","key":"1278_CR65","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1148\/RADIOL.2020200466","volume":"297","author":"PJ Pickhardt","year":"2020","unstructured":"Pickhardt PJ, Graffy PM, Zea R, et al. Automated abdominal CT imaging biomarkers for opportunistic prediction of future major osteoporotic fractures in asymptomatic adults. Radiology. 2020;297(1):64\u201372. https:\/\/doi.org\/10.1148\/RADIOL.2020200466.","journal-title":"Radiology"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01278-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-025-01278-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01278-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:03:46Z","timestamp":1767985426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-025-01278-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1007\/s11934-025-01278-0","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"20 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/Animal Studies Informed Consent Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"51"}}